Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients
Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients Satoshi Murao 1 , Hideichi Makino 2 , Yukikazu Kaino 3 , Etsushi Konoue 4 , Jun Ohashi 5 , Kaichi Kida 3 , Yasuhisa Fujii 6 , Ikki Shimizu 6 , Eiji Kawasa...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 53; no. 10; pp. 2684 - 2690 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.10.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes
in Japanese Patients
Satoshi Murao 1 ,
Hideichi Makino 2 ,
Yukikazu Kaino 3 ,
Etsushi Konoue 4 ,
Jun Ohashi 5 ,
Kaichi Kida 3 ,
Yasuhisa Fujii 6 ,
Ikki Shimizu 6 ,
Eiji Kawasaki 7 ,
Masao Fujiyama 8 ,
Shiori Kondo 4 ,
Kiyonobu Tanaka 9 ,
Yoshinao Tarumi 10 ,
Isamu Seto 11 ,
Kenichi Kato 7 ,
Keizo Ohno 6 ,
Yukiko Kusunoki 6 ,
Osamu Ebisui 6 ,
Yasuharu Takada 9 ,
Katsuya Tanabe 12 ,
Koji Takemoto 3 ,
Hiroshi Onuma 2 ,
Tatsuya Nishimiya 2 and
Haruhiko Osawa 2
1 Matsuyama Shimin Hospital, Ehime, Japan
2 Department of Laboratory Medicine, Ehime University School of Medicine, Ehime, Japan
3 Department of Pediatrics, Ehime University School of Medicine, Ehime, Japan
4 Matsuyama Red Cross Hospital, Ehime, Japan
5 Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
6 Ehime Prefectural Central Hospital, Ehime, Japan
7 Department of Metabolism/Diabetes and Clinical Nutrition, Nagasaki University School of Medicine, Nagasaki, Japan
8 Fujiyama Clinic, Ehime, Japan
9 Saijo Central Hospital, Ehime, Japan
10 Minami Matsuyama Hospital, Ehime, Japan
11 BML, Tokyo, Japan
12 Ehime Rousai Hospital, Ehime, Japan
Address correspondence and reprint requests to Dr. Hideichi Makino, Department of Laboratory Medicine, Ehime University School
of Medicine, Shigenobu, Ehime 791-0295, Japan. E-mail: hidemak{at}m.ehime-u.ac.jp
Abstract
To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on
the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously
reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients
(AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and
190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1*0401 ( DR4 ) and DRB1*0901-DQB1*0303 ( DR9 ), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9 : DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 ( DR8 ), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups ( P < 0.0001), but only DR9 had such an effect in the SO group ( P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes
depending on the clinical phenotype and also indicate that HLA class II haplotypes may be associated with the onset age of
type 1 diabetes.
APC, antigen-presenting cell
LADA, latent autoimmune diabetes in adults
RPE method, relative predispositional effects method
Footnotes
Accepted July 19, 2004.
Received March 28, 2004.
DIABETES |
---|---|
AbstractList | Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes
in Japanese Patients
Satoshi Murao 1 ,
Hideichi Makino 2 ,
Yukikazu Kaino 3 ,
Etsushi Konoue 4 ,
Jun Ohashi 5 ,
Kaichi Kida 3 ,
Yasuhisa Fujii 6 ,
Ikki Shimizu 6 ,
Eiji Kawasaki 7 ,
Masao Fujiyama 8 ,
Shiori Kondo 4 ,
Kiyonobu Tanaka 9 ,
Yoshinao Tarumi 10 ,
Isamu Seto 11 ,
Kenichi Kato 7 ,
Keizo Ohno 6 ,
Yukiko Kusunoki 6 ,
Osamu Ebisui 6 ,
Yasuharu Takada 9 ,
Katsuya Tanabe 12 ,
Koji Takemoto 3 ,
Hiroshi Onuma 2 ,
Tatsuya Nishimiya 2 and
Haruhiko Osawa 2
1 Matsuyama Shimin Hospital, Ehime, Japan
2 Department of Laboratory Medicine, Ehime University School of Medicine, Ehime, Japan
3 Department of Pediatrics, Ehime University School of Medicine, Ehime, Japan
4 Matsuyama Red Cross Hospital, Ehime, Japan
5 Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
6 Ehime Prefectural Central Hospital, Ehime, Japan
7 Department of Metabolism/Diabetes and Clinical Nutrition, Nagasaki University School of Medicine, Nagasaki, Japan
8 Fujiyama Clinic, Ehime, Japan
9 Saijo Central Hospital, Ehime, Japan
10 Minami Matsuyama Hospital, Ehime, Japan
11 BML, Tokyo, Japan
12 Ehime Rousai Hospital, Ehime, Japan
Address correspondence and reprint requests to Dr. Hideichi Makino, Department of Laboratory Medicine, Ehime University School
of Medicine, Shigenobu, Ehime 791-0295, Japan. E-mail: hidemak{at}m.ehime-u.ac.jp
Abstract
To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on
the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously
reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients
(AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and
190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1*0401 ( DR4 ) and DRB1*0901-DQB1*0303 ( DR9 ), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9 : DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 ( DR8 ), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups ( P < 0.0001), but only DR9 had such an effect in the SO group ( P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes
depending on the clinical phenotype and also indicate that HLA class II haplotypes may be associated with the onset age of
type 1 diabetes.
APC, antigen-presenting cell
LADA, latent autoimmune diabetes in adults
RPE method, relative predispositional effects method
Footnotes
Accepted July 19, 2004.
Received March 28, 2004.
DIABETES To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients (AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and 190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1 DQB1 (DR4) and DRB1 *0901-DQB1*0303 (DR9), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9:DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 (DR8), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups (P < 0.0001), but only DR9 had such an effect in the SO group (P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes depending on the clinical phenotype and also indicate that HLA class Il haplotypes may be associated with the onset age of type 1 diabetes. To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients (AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and 190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1*0401 (DR4) and DRB1*0901-DQB1*0303 (DR9), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9:DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 (DR8), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups (P < 0.0001), but only DR9 had such an effect in the SO group (P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes depending on the clinical phenotype and also indicate that HLA class II haplotypes may be associated with the onset age of type 1 diabetes. To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients (AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and 190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1*0401 (DR4) and DRB1*0901-DQB1*0303 (DR9), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9:DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 (DR8), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups (P < 0.0001), but only DR9 had such an effect in the SO group (P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes depending on the clinical phenotype and also indicate that HLA class II haplotypes may be associated with the onset age of type 1 diabetes. |
Audience | Professional |
Author | Etsushi Konoue Koji Takemoto Haruhiko Osawa Yukikazu Kaino Katsuya Tanabe Jun Ohashi Ikki Shimizu Hideichi Makino Hiroshi Onuma Shiori Kondo Eiji Kawasaki Isamu Seto Kenichi Kato Kiyonobu Tanaka Yukiko Kusunoki Satoshi Murao Osamu Ebisui Tatsuya Nishimiya Yasuhisa Fujii Masao Fujiyama Yoshinao Tarumi Yasuharu Takada Kaichi Kida Keizo Ohno |
Author_xml | – sequence: 1 givenname: Satoshi surname: MURAO fullname: MURAO, Satoshi organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 2 givenname: Hideichi surname: MAKINO fullname: MAKINO, Hideichi organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 3 givenname: Shiori surname: KONDO fullname: KONDO, Shiori organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 4 givenname: Kiyonobu surname: TANAKA fullname: TANAKA, Kiyonobu organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 5 givenname: Yoshinao surname: TARUMI fullname: TARUMI, Yoshinao organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 6 givenname: Isamu surname: SETO fullname: SETO, Isamu organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 7 givenname: Kenichi surname: KATO fullname: KATO, Kenichi organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 8 givenname: Keizo surname: OHNO fullname: OHNO, Keizo organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 9 givenname: Yukiko surname: KUSUNOKI fullname: KUSUNOKI, Yukiko organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 10 givenname: Osamu surname: EBISUI fullname: EBISUI, Osamu organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 11 givenname: Yasuharu surname: TAKADA fullname: TAKADA, Yasuharu organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 12 givenname: Katsuya surname: TANABE fullname: TANABE, Katsuya organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 13 givenname: Yukikazu surname: KAINO fullname: KAINO, Yukikazu organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 14 givenname: Koji surname: TAKEMOTO fullname: TAKEMOTO, Koji organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 15 givenname: Hiroshi surname: ONUMA fullname: ONUMA, Hiroshi organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 16 givenname: Tatsuya surname: NISHIMIYA fullname: NISHIMIYA, Tatsuya organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 17 givenname: Haruhiko surname: OSAWA fullname: OSAWA, Haruhiko organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 18 givenname: Etsushi surname: KONOUE fullname: KONOUE, Etsushi organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 19 givenname: Jun surname: OHASHI fullname: OHASHI, Jun organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 20 givenname: Kaichi surname: KIDA fullname: KIDA, Kaichi organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 21 givenname: Yasuhisa surname: FUJII fullname: FUJII, Yasuhisa organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 22 givenname: Ikki surname: SHIMIZU fullname: SHIMIZU, Ikki organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 23 givenname: Eiji surname: KAWASAKI fullname: KAWASAKI, Eiji organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan – sequence: 24 givenname: Masao surname: FUJIYAMA fullname: FUJIYAMA, Masao organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16157334$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15448101$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkm2r0zAUx4tc8T7oJxAkCAqCnTlNm7Yvx6Z3ymA-XMF3JU1Ot1y6pLdJ0X0Mv7Hp3WRMLsh5ETj8_ucp_8vozFiDUfQc6CRhLH-ntKjRo5tkbDLmeJE-ii6gZGXMkvzHWXRBKSQx5GV-Hl06d0sp5SGeROeQpWkBFC6i33PdNNijkeiINsRvkMys8b2uB6-tIbYhi-U0nn8lwigSz7-Qheha63ddEHhLvg1OYud1rVvtd2NmqobWx_f4bKNbtbFWxSvj0JOboCJA5ofJx4afRCcMOiSfhddovHsaPW5E6_DZ4b2Kvn94fzNbxMvV9cfZdBlLnhY-TmWJGecM0gSUKjJQRd1kFBohQbJS1WmhGK2FqFPVyDJhSQZZlpRCKkWLcMCr6PW-btfbuwGdr7Y6rNK2YRw7uIrzEsqcZ_8FoaApB8gD-PIf8NYOvQlLVAmEoTkUEKDJHlqLFittGut7IUMo3GoZfrjRIT-FhNGCpdlY9c2JIDAef_m1GJyriuvlKRs_xErbtrjGKtxvtjrl2Z6XvXWux6bqer0V_a4CWo0mq_6arMrYfS6YLKheHPYc6i2qo-bgqgC8OgDCSdE2vTBSuyPHIfRmY6G3e26j15ufusdju4f6_gEN_upE |
CODEN | DIAEAZ |
CitedBy_id | crossref_primary_10_2174_1871530323666221111153102 crossref_primary_10_3143_geriatrics_53_143 crossref_primary_10_1002_dmrr_571 crossref_primary_10_1111_j_1744_313X_2008_00749_x crossref_primary_10_1155_2017_6924637 crossref_primary_10_1507_endocrj_KR_72 crossref_primary_10_3390_biology11111662 crossref_primary_10_1016_j_diabres_2005_12_007 crossref_primary_10_3389_fimmu_2022_952099 crossref_primary_10_2337_diacare_28_9_2330 crossref_primary_10_3143_geriatrics_48_565 crossref_primary_10_4103_ijem_IJEM_564_19 crossref_primary_10_1093_rheumatology_kes427 crossref_primary_10_1097_CCM_0b013e318183f608 crossref_primary_10_1007_s00125_009_1539_9 crossref_primary_10_4049_jimmunol_0802228 crossref_primary_10_1111_jdi_13091 crossref_primary_10_1507_endocrj_K09E_074 crossref_primary_10_2169_naika_95_1129 crossref_primary_10_2169_internalmedicine_52_0932 crossref_primary_10_1196_annals_1375_009 crossref_primary_10_1210_clinem_dgab589 crossref_primary_10_1210_clinem_dgad329 crossref_primary_10_1177_09612033221100156 crossref_primary_10_2337_dc09_1210 crossref_primary_10_1016_j_diabres_2007_08_031 crossref_primary_10_1155_2012_457546 crossref_primary_10_1016_j_humimm_2010_05_020 crossref_primary_10_1007_s13340_018_0362_2 crossref_primary_10_1111_j_1872_034X_2010_00753_x crossref_primary_10_1590_S0004_27302006000300005 crossref_primary_10_3918_jsicm_22_273 crossref_primary_10_1002_dmrr_1148 crossref_primary_10_1210_jc_2012_2054 crossref_primary_10_1007_s10654_005_5081_x crossref_primary_10_1016_j_jdiacomp_2024_108763 crossref_primary_10_1038_ncpendmet0351 crossref_primary_10_1297_cpe_17_113 crossref_primary_10_1007_s13340_021_00541_2 crossref_primary_10_1111_j_1464_5491_2012_03623_x crossref_primary_10_1111_j_1399_0039_2007_00867_x crossref_primary_10_1111_j_1399_0039_2007_00916_x crossref_primary_10_1016_j_jaci_2020_01_011 crossref_primary_10_1111_j_1399_5448_2011_00833_x crossref_primary_10_1196_annals_1337_006 crossref_primary_10_1016_j_diabres_2011_03_025 crossref_primary_10_1016_j_diabres_2008_01_024 crossref_primary_10_1007_s13340_024_00719_4 crossref_primary_10_1002_dmrr_3357 crossref_primary_10_1007_s13340_020_00448_4 crossref_primary_10_1016_j_jaut_2010_12_004 crossref_primary_10_1089_gtmb_2012_0221 crossref_primary_10_1111_j_2040_1124_2011_00139_x crossref_primary_10_1177_0148607112462401 crossref_primary_10_14341_2072_0351_6080 crossref_primary_10_1155_2012_657156 crossref_primary_10_1021_pr300523x crossref_primary_10_1186_1423_0127_20_12 |
Cites_doi | 10.2337/diacare.8.2.114 10.1111/j.1464-5491.1994.tb00327.x 10.1007/BF00454876 10.1007/s001250051202 10.2337/diacare.26.8.2345 10.1111/j.1399-0039.1991.tb01854.x 10.1038/346574a0 10.2337/diacare.16.5.780 10.1038/371130a0 10.1111/j.1399-0039.1994.tb02375.x 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 10.1016/S0198-8859(00)00118-X 10.1046/j.1464-5491.2000.00205.x 10.1111/j.1464-5491.1994.tb00275.x 10.1016/S0198-8859(01)00301-9 10.1016/S0168-8227(03)00147-5 10.1056/NEJM200002033420501 10.1093/hmg/10.19.2025 10.1056/NEJM198904063201401 10.1016/0198-8859(94)00075-2 10.1016/S0198-8859(97)00186-9 10.2337/diacare.20.4.524 10.1006/jaut.1996.0089 10.1006/jaut.1999.0315 10.1056/NEJM199006283222602 10.1016/S0168-8227(85)80006-1 10.2337/diacare.20.7.1183 10.2337/diabetes.51.2.545 10.1172/JCI116110 10.1007/BF02342437 10.2337/diacare.25.12.2302 10.3109/08830189809054404 10.2337/diabetes.46.11.1893 10.2337/diacare.25.6.995 10.1016/S0140-6736(01)05415-0 10.1111/j.1399-0039.1996.tb02512.x 10.1007/BF00265401 10.2337/diab.41.3.378 10.2337/diabetes.48.1.150 10.1172/JCI14257 |
ContentType | Journal Article |
Copyright | 2004 INIST-CNRS COPYRIGHT 2004 American Diabetes Association COPYRIGHT 2004 American Diabetes Association Copyright American Diabetes Association Oct 2004 |
Copyright_xml | – notice: 2004 INIST-CNRS – notice: COPYRIGHT 2004 American Diabetes Association – notice: COPYRIGHT 2004 American Diabetes Association – notice: Copyright American Diabetes Association Oct 2004 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 8GL 3V. 7RV 7X7 7XB 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9- K9. KB0 LK8 M0R M0S M1P M2O M2P M7P MBDVC NAPCQ PQEST PQQKQ PQUKI PRINS Q9U S0X 7T5 H94 7X8 |
DOI | 10.2337/diabetes.53.10.2684 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: High School ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Complete (ProQuest Database) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection ProQuest Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep SciTech Premium Collection Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Consumer Health Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Research Library (ProQuest Database) Science Journals (ProQuest Database) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student ProQuest Central Essentials SIRS Editorial elibrary ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Research Library Prep AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
EndPage | 2690 |
ExternalDocumentID | 709783141 A123083457 10_2337_diabetes_53_10_2684 15448101 16157334 diabetes_53_10_2684 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | - 08R 0R 1AW 29F 2WC 3V. 4.4 53G 55 5GY 5RE 5RS 5VS 7RV 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8GL 8R4 8R5 AAQQT AAWTL AAYEP AAYJJ ABFLS ABOCM ABPTK ABUWG ACDCL ACGOD ACPRK ADACO ADBBV ADBIT AENEX AFFNX AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBAFP BBNVY BCR BCU BEC BENPR BES BHPHI BKEYQ BKNYI BLC BPHCQ BVXVI C1A CS3 DIK DU5 DWQXO E3Z EBS EDB EJD EX3 F5P FRP FYUFA GICCO GJ GNUQQ GUQSH GX1 H13 HCIFZ HZ IAG IAO IEA IHR INH INR IOF IPO J5H K-O K9- KM KQ8 L7B LK8 M0R M1P M2O M2P M2Q M5 M7P MBDVC O0- O9- OB3 OBH OK1 OVD P2P PADUT PCD PEA PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q2X RHF RHI RPM S0X SJFOW SJN SV3 TDI WH7 WOQ WOW X7M XZ ZA5 ZGI ZXP ZY1 --- .55 .GJ .XZ 08P 0R~ 18M 1CY 354 6PF AAKAS AAUGY AAYOK ACGFO ADZCM AEGXH AERZD AFHIN AI. AIAGR BTFSW CCPQU EMOBN HZ~ H~9 IQODW ITC K2M M5~ MVM N4W NAPCQ O5R O5S OHH TEORI TR2 UKHRP VH1 VVN W8F XOL YFH YHG YOC YQJ ~KM AIZAD ALIPV CGR CUY CVF ECM EIF HMCUK NPM AAYXX CITATION 7XB 8FK K9. Q9U 7T5 H94 7X8 |
ID | FETCH-LOGICAL-c648t-4c9e56631421dd851d8bf501fac1c39db48d30baab4dfc9232515529acdd08233 |
IEDL.DBID | 8C1 |
ISSN | 0012-1797 |
IngestDate | Fri Oct 25 05:00:35 EDT 2024 Fri Aug 16 22:12:48 EDT 2024 Thu Oct 10 19:59:14 EDT 2024 Wed Nov 13 00:09:23 EST 2024 Thu Aug 01 20:09:28 EDT 2024 Thu Aug 22 20:39:03 EDT 2024 Fri Aug 23 02:43:58 EDT 2024 Sat Sep 28 08:38:36 EDT 2024 Sun Oct 22 16:06:43 EDT 2023 Fri Jan 15 19:45:55 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Endocrinopathy Human HLA-System Sensitivity Type 1 diabetes Haplotype Japanese |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c648t-4c9e56631421dd851d8bf501fac1c39db48d30baab4dfc9232515529acdd08233 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://diabetesjournals.org/diabetes/article-pdf/53/10/2684/373631/zdb01004002684.pdf |
PMID | 15448101 |
PQID | 216486181 |
PQPubID | 34443 |
PageCount | 7 |
ParticipantIDs | proquest_journals_216486181 proquest_miscellaneous_66919765 gale_infotracacademiconefile_A123083457 gale_incontextgauss_8GL_A123083457 highwire_diabetes_diabetes_53_10_2684 gale_incontextcollege_GICCO_A123083457 pubmed_primary_15448101 proquest_miscellaneous_18046117 pascalfrancis_primary_16157334 crossref_primary_10_2337_diabetes_53_10_2684 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 2004-10-01 |
PublicationDateYYYYMMDD | 2004-10-01 |
PublicationDate_xml | – month: 10 year: 2004 text: 2004-10-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Alexandria, VA |
PublicationPlace_xml | – name: Alexandria, VA – name: United States – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationTitleAlternate | Diabetes |
PublicationYear | 2004 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | 2022031207303499100_R41 2022031207303499100_R20 2022031207303499100_R42 2022031207303499100_R40 2022031207303499100_R1 2022031207303499100_R23 2022031207303499100_R2 2022031207303499100_R24 2022031207303499100_R3 2022031207303499100_R21 2022031207303499100_R4 2022031207303499100_R22 2022031207303499100_R5 2022031207303499100_R6 2022031207303499100_R7 2022031207303499100_R8 2022031207303499100_R9 2022031207303499100_R16 2022031207303499100_R38 2022031207303499100_R17 2022031207303499100_R39 2022031207303499100_R14 2022031207303499100_R36 2022031207303499100_R15 2022031207303499100_R37 2022031207303499100_R18 2022031207303499100_R19 2022031207303499100_R30 2022031207303499100_R31 2022031207303499100_R12 2022031207303499100_R34 2022031207303499100_R13 2022031207303499100_R35 2022031207303499100_R10 2022031207303499100_R32 2022031207303499100_R11 2022031207303499100_R33 2022031207303499100_R27 2022031207303499100_R28 2022031207303499100_R25 2022031207303499100_R26 2022031207303499100_R29 |
References_xml | – ident: 2022031207303499100_R3 doi: 10.2337/diacare.8.2.114 – ident: 2022031207303499100_R10 – ident: 2022031207303499100_R4 doi: 10.1111/j.1464-5491.1994.tb00327.x – ident: 2022031207303499100_R38 doi: 10.1007/BF00454876 – ident: 2022031207303499100_R32 doi: 10.1007/s001250051202 – ident: 2022031207303499100_R34 doi: 10.2337/diacare.26.8.2345 – ident: 2022031207303499100_R37 doi: 10.1111/j.1399-0039.1991.tb01854.x – ident: 2022031207303499100_R40 doi: 10.1038/346574a0 – ident: 2022031207303499100_R6 doi: 10.2337/diacare.16.5.780 – ident: 2022031207303499100_R8 doi: 10.1038/371130a0 – ident: 2022031207303499100_R33 – ident: 2022031207303499100_R12 doi: 10.1111/j.1399-0039.1994.tb02375.x – ident: 2022031207303499100_R25 doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S – ident: 2022031207303499100_R41 doi: 10.1016/S0198-8859(00)00118-X – ident: 2022031207303499100_R28 doi: 10.1046/j.1464-5491.2000.00205.x – ident: 2022031207303499100_R7 doi: 10.1111/j.1464-5491.1994.tb00275.x – ident: 2022031207303499100_R9 doi: 10.1016/S0198-8859(01)00301-9 – ident: 2022031207303499100_R23 doi: 10.1016/S0168-8227(03)00147-5 – ident: 2022031207303499100_R5 doi: 10.1056/NEJM200002033420501 – ident: 2022031207303499100_R11 doi: 10.1093/hmg/10.19.2025 – ident: 2022031207303499100_R16 doi: 10.1056/NEJM198904063201401 – ident: 2022031207303499100_R18 doi: 10.1016/0198-8859(94)00075-2 – ident: 2022031207303499100_R19 doi: 10.1016/S0198-8859(97)00186-9 – ident: 2022031207303499100_R20 doi: 10.2337/diacare.20.4.524 – ident: 2022031207303499100_R30 doi: 10.1006/jaut.1996.0089 – ident: 2022031207303499100_R31 doi: 10.1006/jaut.1999.0315 – ident: 2022031207303499100_R35 doi: 10.1056/NEJM199006283222602 – ident: 2022031207303499100_R29 doi: 10.1016/S0168-8227(85)80006-1 – ident: 2022031207303499100_R24 doi: 10.2337/diacare.20.7.1183 – ident: 2022031207303499100_R15 doi: 10.2337/diabetes.51.2.545 – ident: 2022031207303499100_R17 doi: 10.1172/JCI116110 – ident: 2022031207303499100_R13 doi: 10.1007/BF02342437 – ident: 2022031207303499100_R22 doi: 10.2337/diacare.25.12.2302 – ident: 2022031207303499100_R39 doi: 10.3109/08830189809054404 – ident: 2022031207303499100_R42 doi: 10.2337/diabetes.46.11.1893 – ident: 2022031207303499100_R26 doi: 10.2337/diacare.25.6.995 – ident: 2022031207303499100_R2 doi: 10.1016/S0140-6736(01)05415-0 – ident: 2022031207303499100_R14 doi: 10.1111/j.1399-0039.1996.tb02512.x – ident: 2022031207303499100_R27 doi: 10.1007/BF00265401 – ident: 2022031207303499100_R36 doi: 10.2337/diab.41.3.378 – ident: 2022031207303499100_R21 doi: 10.2337/diabetes.48.1.150 – ident: 2022031207303499100_R1 doi: 10.1172/JCI14257 |
SSID | ssj0006060 |
Score | 2.1193974 |
Snippet | Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes
in Japanese Patients
Satoshi Murao... To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared... |
SourceID | proquest gale crossref pubmed pascalfrancis highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2684 |
SubjectTerms | Adult Age of Onset Biological and medical sciences Care and treatment Child Diabetes Mellitus, Type 1 - epidemiology Diabetes Mellitus, Type 1 - genetics Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Gene Frequency Genetic Predisposition to Disease - genetics Haplotypes HLA-DQ Antigens - genetics HLA-DR Antigens - genetics Humans Japan - epidemiology Medical sciences Type 1 diabetes |
Title | Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients |
URI | http://diabetes.diabetesjournals.org/content/53/10/2684.abstract https://www.ncbi.nlm.nih.gov/pubmed/15448101 https://www.proquest.com/docview/216486181 https://search.proquest.com/docview/18046117 https://search.proquest.com/docview/66919765 |
Volume | 53 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZoKyEuiHdDYbEQjwtu17GTOCe07Lasqr4oVNqb5TyMKlXJUmcP_Az-MTOJs6tIlGt2JHsz45nP9pdvCHkHNS6ymTFMqsIyacOEpVIJWHgK8EFaGttKCp2exfMrebyIFp6b4zytss-JbaIu6hzPyA9CwPUqhnr0efmLYdMovFz1HTS2yA6HMoeMPjXdMDwAm3dfoPAQVTiTTnQoFCI56A829yOxj89iJQeFqU_PvWYwUiaNg7dmu3YXd-PRti4dPSIPPaCkky4CHpN7ZfWE3D_1V-ZPyZ-Zb4ECCYFeVxQAH0VJqr7RFa0tnZ9M2OySmqqgbPaNzs3ypsazWUebmn5fuZb60rJof-OTCWp2sNZ8rYzMzitXNhS3tZRTz7NpBzyGcoxtLulFJ-HqnpGro8Mf0znzfRhYDu-8YTJPS0B9gsuQFwVAtEJlNhpza3Kei7TIwM9iDA7PZGFzQIwh9o0JU5MXBV7kiedku6qrcpdQxPJGRcaCoUy5MePcyFJmAGqEkmkWkE-9E_Syk9vQsE1Bn-neZzoS7TPwWUA-oKM0CllUyJTJu9MWDdOfnusJlGWAmDJKAvJ2aPjTrJzT6uvJwOijN7J1c2ty479QgKmjSNbA8n0fGZtp_XN-o0HYbP4TAMlECDDY6-NI--Th9DrUA_Jm_SuserzKAYfVK6e5QqF8ntxtEccpB6gZBeRFF56bsSPYkkMmfvnfsffIg07TEnmLr8h2c7sqXwP-arIR2UoWyahdayOy8-Xw7OLyLxBsL6c |
link.rule.ids | 315,783,787,12068,12235,21400,27936,27937,31731,31732,33278,33279,33756,33757,43322,43591,43817,74073,74342,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSMAF8SYUWgvxuOB2HTuJc0KrXUoouy2PVurNcpwYIaFkabIHfgb_mJnE2VUkytUZyY5nPPPZHn9DyEuIcZHLjWFSFY5JFyYslUrAwlOAD9LSuI5SaHkSZ-fy-CK68Lk5jU-rHHxi56iL2uIZ-WEIuF7FEI_erX4xLBqFl6u-gsZ1cgOiforrUs22GR6AzfsXKDxEFs6kJx0KhUgOh4PNg0gcYFus5CgwDe554AzGlEnTwKy5vtzF1Xi0i0tHd8kdDyjptLeAe-RaWd0nN5f-yvwB-TP3JVDAIdAfFQXAR5GSaih0RWtHs8WUzb9SUxWUzb_QzKx-1ng229C2pt_WTZf60mXR_saWKXJ2sE58w4zMTqumbCluaymnPs-m6_AYwjGWuaSfewrX5iE5P3p_NsuYr8PALMx5y6RNS0B9gsuQFwVAtELlLppwZyy3Ii1y0LOYgMJzWTgLiDHEujFhamxR4EWeeER2qroqnxCKWN6oyDgQlCk3ZmKNLGUOoEYomeYBeTsoQa96ug0N2xTUmR50piPRtYHOAvIaFaWRyKLCTBnbn7ZoGP7sVE8hLAPElFESkBdjwe9m3TRafViMhN54IVe3l8Ya_0IBho4kWSPJV4NlbIf1z_Htjcxm-08AJBMhQGB3sCPtnUejN6YekP3NV1j1eJUDCqvXjeYKifJ5crVEHKccoGYUkMe9eW77jmBLDp746X_73ie3srPlQi8-nnzaJbd7fkvMYXxGdtrLdfkcsFib73Ur7i_pdzAZ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegkyZeEN9kg81CfLzgtYmdxHlCZV0po-vKYNLeLOfDaBJKypw-8GfwH3OXOK0iMV6dk-zkznc_-y6_I-Q1xLjQpFozIXPDhAlilgjJYeNJwAdJoU1DKXS2iGaX4vQqvHKUQtaVVXY-sXHUeZXhHfkwAFwvI4hHQ-OqIpaT6YfVL4YNpDDR6rpp3CU7sYj4aEB2Pp4slhcbtwxIvf0fxQ-QkzNuKYgCzuNhd815FPIjHIuk6IWpzll3DMJYQKktfEPTNr-4HZ02UWr6gNx38JKOW3t4SO4U5SOye-YS6I_Jn4lriALugV6XFOAfRYKqru0VrQydzcdsckF1mVM2-UpnevWzwptaS-uKflvbphCmqan9jSNjZPBgjfiGJ5mdl7aoKR5yqU9d1U0z4SkEZ2x6SZctoat9Qi6nJ9-PZ8x1ZWAZaKBmIksKwIDcF4Gf5wDYcpmacOQbnfkZT_IUtM5HoP5U5CYD_BhgF5kg0VmeY1qPPyWDsiqL54Qistcy1AYEReJrPcq0KEQKEIdLkaQeed8pQa1a8g0FhxbUmep0pkLejIHOPPIWFaWQ1qJEC8nauxcFyz8-V2MI0gA4RRh75FVf8IdeW6vkp3lP6J0TMlV9ozPt_leApSNlVk_yTWcZ22X9c30HPbPZvhPAyphzENjv7Eg5V2LVxvA9crh5Cj4AEzugsGptlS-RNt-Pb5eIosQH4Bl65Flrntu5Qzigg1_e--_ch2QXtpuaf1582Sf3WrJLLGh8QQb1zbp4CcCsTg_clvsL0Rg14g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differences+in+the+Contribution+of+HLA-DR+and+-DQ+Haplotypes+to+Susceptibility+to+Adult-+and+Childhood-Onset+Type+1+Diabetes+in+Japanese+Patients&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Murao%2C+Satoshi&rft.au=Makino%2C+Hideichi&rft.au=Kaino%2C+Yukikazu&rft.au=Konoue%2C+Etsushi&rft.date=2004-10-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=53&rft.issue=10&rft.spage=2684&rft_id=info:doi/10.2337%2Fdiabetes.53.10.2684&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=709783141 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |